知情健康选择播客对乌干达小学生家长评估治疗效应声明能力的影响:一项随机对照试验
在乌干达中部35所学校招募675名10-12岁小学生的家长,随机分为播客组(n=334)和公益广告对照组(n=341)。播客组评估治疗效应声明的平均得分为67.8%(SD 19.6),对照组为52.4%(17.6),调整后平均差15.5%(95%CI 12.5-18.6;p<0.0001);播客组通过率71%(203/288),对照组38%(103/273),调整后差34%(95%CI 26-41;p<0.0001)。
要点
- 收听知情健康选择播客使家长评估治疗效应声明的平均得分提高15.5个百分点(95%CI 12.5-18.6)。
- 播客组通过率71%(203/288),对照组38%(103/273),调整后差34%(95%CI 26-41)。
- 未报告不良事件。
核心结论
- 收听知情健康选择播客大幅提高了家长评估治疗效应声明的能力。
- 未来研究应评估使用播客的长期效应、对实际健康选择和结局的影响,以及研究结果对其他国家的可推广性。
研究设计与样本
- 在乌干达中部35所参与知情健康选择小学资源关联试验的学校中,招募10-12岁五年级儿童的家长。
- 采用随机对照试验,通过基于网络的随机数生成器按1:1随机分配(区组大小为4和6),按家长最高正规教育程度和其子女学校在试验中的分配进行分层。
- 干预组收听知情健康选择播客,对照组收听关于健康问题的典型公益广告。
- 主要结局为收听整个播客后的平均得分和通过率,测试包含9个关键概念各2道多选题(共18题)。
- 采用意向性治疗分析;试验注册号PACTR201606001676150。
主要发现
- 2016年7月21日至2016年10月7日招募家长,随机分配675名家长至播客组(n=334)或公益广告组(n=341);561名(83%)完成随访。
- 播客组家长平均得分为67.8%(SD 19.6),对照组为52.4%(17.6),调整后平均差15.5%(95%CI 12.5-18.6;p<0.0001)。
- 播客组288名家长中203名(71%)达到预定通过分数(≥11/18正确),对照组273名家长中103名(38%)达到,调整后差34%(95%CI 26-41;p<0.0001)。
- 未报告不良事件。
关键数值与推荐
- 主要结局通过分数定义为18题中正确回答≥11题。
- 播客组平均得分67.8%(SD 19.6) vs 对照组52.4%(17.6),调整后平均差15.5%(95%CI 12.5-18.6;p<0.0001)。
- 播客组通过率71%(203/288) vs 对照组38%(103/273),调整后差34%(95%CI 26-41;p<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 未来研究应评估使用播客的长期效应。
- 未来研究应评估对实际健康选择和结局的影响。
- 未来研究应评估研究结果对其他国家的可推广性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As part of the Informed Health Choices project, we developed a podcast called The Health Choices Programme to help improve the ability of people to assess claims about the benefits and harms of treatments. We aimed to evaluate the effects of the podcast on the ability of parents of primary school children in Uganda to assess claims about the effects of treatments. METHODS: We did this randomised controlled trial in central Uganda. We recruited parents of children aged 10-12 years who were in their fifth year of school at 35 schools that were participating in a linked trial of the Informed Health Choices primary school resources. The parents were randomly allocated (1:1), via a web-based random number generator with block sizes of four and six, to listen to either the Informed Health Choices podcast (intervention group) or typical public service announcements about health issues (control group). Randomisation was stratified by parents' highest level of formal education attained (primary school, secondary school, or tertiary education) and the allocation of their children's school in the trial of the primary school resources (intervention vs control). The primary outcome, measured after listening to the entire podcast, was the mean score and the proportion of parents with passing scores on a test with two multiple choice questions for each of nine key concepts essential to assessing claims about treatments (18 questions in total). We did intention-to-treat analyses. This trial is registered with the Pan African Clinical Trial Registry, number PACTR201606001676150. FINDINGS: We recruited parents between July 21, 2016, and Oct 7, 2016. We randomly assigned 675 parents to the podcast group (n=334) or the public service announcement group (n=341); 561 (83%) participants completed follow-up. The mean score for parents in the podcast group was 67·8% (SD 19·6) compared with 52·4% (17·6) in the control group (adjusted mean difference 15·5%, 95% CI 12·5-18·6; p<0·0001). In the podcast group, 203 (71%) of 288 parents had a predetermined passing score (≥11 of 18 correct answers) compared with 103 (38%) of 273 parents in the control group (adjusted difference 34%, 95% CI 26-41; p<0·0001). No adverse events were reported. INTERPRETATION: Listening to the Informed Health Choices podcast led to a large improvement in the ability of parents to assess claims about the effects of treatments. Future studies should assess the long-term effects of use of the podcast, the effects on actual health choices and outcomes, and how transferable our findings are to other countries. FUNDING: Research Council of Norway.
引用
- Semakula D, Nsangi A, Oxman AD, et al. Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trial. Lancet. 2017. PMID: 28539196. doi:10.1016/S0140-6736(17)31225-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。